Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
- de Souza, William Marciel
- Buss, Lewis Fletcher
- Candido, Darlan da Silva
- Carrera, Jean-Paul
- Li, Sabrina
- Zarebski, Alexander E.
- Pereira, Rafael Henrique Moraes
- Prete, Carlos A.
- de Souza-Santos, Andreza Aruska
- Parag, Kris V.
- Belotti, Maria Carolina T. D.
- Vincenti-Gonzalez, Maria F.
- Messina, Janey
- da Silva Sales, Flavia Cristina
- Andrade, Pamela dos Santos
- Nascimento, Vitor Heloiz
- Ghilardi, Fabio
- Abade, Leandro
- Gutierrez, Bernardo
- Kraemer, Moritz U. G.
- Braga, Carlos K. V.
- Aguiar, Renato Santana
- Alexander, Neal
- Mayaud, Philippe
- Brady, Oliver J.
- Marcilio, Izabel
- Gouveia, Nelson
- Li, Guangdi
- Tami, Adriana
- de Oliveira, Silvano Barbosa
- Porto, Victor Bertollo Gomes
- Ganem, Fabiana
- de Almeida, Walquiria Aparecida Ferreira
- Fantinato, Francieli Fontana Sutile Tardetti
- Macario, Eduardo Marques
- de Oliveira, Wanderson Kleber
- Nogueira, Mauricio L.
- Pybus, Oliver G.
- Wu, Chieh-Hsi
- Croda, Julio
- Sabino, Ester C.
- Faria, Nuno Rodrigues
DOIAbstract
The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and contextualize epidemiological, demographic and clinical findings for COVID-19 cases during the first 3 months of the epidemic. By 31 May 2020, 514,200 COVID-19 cases, including 29,314 deaths, had been reported in 75.3% (4,196 of 5,570) of municipalities across all five administrative regions of Brazil. The R0 value for Brazil was estimated at 3.1 (95% Bayesian credible interval = 2.4–5.5), with a higher median but overlapping credible intervals compared with some other seriously affected countries. A positive association between higher per-capita income and COVID-19 diagnosis was identified. Furthermore, the severe acute respiratory infection cases with unk...
Add to ORKG